Immunogenous and Protective Abilities of Recombinant Vaccine Against Canine Borreliosis
World Small Animal Veterinary Association World Congress Proceedings, 2006
V. Vrzal1, J. Tuháčková1, J. Neperený1, J. Chumela1, E. Weigl2
1Bioveta, Ivanovice na Hané, Czech Republic; 2Faculty of Medicine, Palacky University, Olomouc, Czech Republic

Ten dogs were vaccinated using an experimental vaccine containing recombinant OspA and OspC proteins of serospecies Borrelia burgdorferi, Borrelia afzelii and Borrelia garinii. Two dogs without vaccination were used as controls. A challenge test was accomplished using the natural way of contact (with infected common ticks - Ixodes ricinus). Blood samples for serological examination were collected after the immunisation prior to and after the challenge. An autopsy was performed 2 months after the challenge and samples were collected for the culture detection of borrelia from the predilection organs. Culture detection was performed also after the challenge prior to autopsy from biopsy skin samples. It was verified that the experimental recombinant vaccine induces specific antibodies against OspA and OspC proteins and results in protection against borrelia during natural infection from common ticks - Ixodes ricinus. Results from project of MPO - FD-K3/100 were used in the presentation.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

V. Vrzal
Ivanovice na Hané
Czech Republic

MAIN : Posters – Abstracts : Canine Borreliosis Vaccine
Powered By VIN